Canada Pension Plan Investment Board, a global investment management organization, is set to invest $100m in Chi-Med, a developer, manufacturer, and distributor pharmaceutical products. “This placement aligns with CPP Investments’ focus on providing strategic, long-term capital to industry leading companies where we can participate in the future success of the business and help create greater value through ongoing partnership. We look forward to supporting Chi-Med’s work on innovation in oncology treatment," Agus Tandiono, CPPIB Managing Director and Head of Fundamental Equities Asia.